Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
PH-762 by Phio Pharmaceuticals for Merkel Cell Carcinoma: Likelihood of Approval
PH-762 is under clinical development by Phio Pharmaceuticals and currently in Phase I for Merkel Cell Carcinoma. According to GlobalData,...
Data Insights
PH-762 by Phio Pharmaceuticals for Metastatic Melanoma: Likelihood of Approval
PH-762 is under clinical development by Phio Pharmaceuticals and currently in Phase I for Metastatic Melanoma. According to GlobalData, Phase...